Canakinumab Subcutaneous and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
Determining the interaction of Canakinumab Subcutaneous and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Omeclamox-Pak
- Canakinumab Subcutaneous-Omega-3 Fatty Acid Capsules
- Canakinumab Subcutaneous-Omega-3 Fatty Acids
- Canakinumab Subcutaneous-Omega-3 polyunsaturated fatty acids
- Canakinumab Subcutaneous-Omega-3-acid ethyl esters
- Canakinumab Subcutaneous-Omega-3-carboxylic acids
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Canasa
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Canasa Pac rectal
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Canasa rectal
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Cancidas
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Candesartan
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Candesartan and Hydrochlorothiazide